title: Should We Start Community Screening for Left Ventricular Dysfunction?
authors.affiliation: VA Palo Alto Health Care System, Stanford University, Palo Alto, CA, USA. Electronic address: heiden@stanford.edu.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Heidenreich
mesh_terms: D006801:Humans; D008403:Mass Screening; D020097:Natriuretic Peptide, Brain; D012111:Residence Characteristics; D018487:Ventricular Dysfunction, Left
chemical_list: D020097:Natriuretic Peptide, Brain